Details for Patent: 8,829,054
✉ Email this page to a colleague
Which drugs does patent 8,829,054 protect, and when does it expire?
Patent 8,829,054 protects ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER and ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER and is included in one NDA.
This patent has seven patent family members in seven countries.
Summary for Patent: 8,829,054
| Title: | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
| Abstract: | A ready-to-use injectable, co-solvents (ternary mixture) pharmaceutical composition for the treatment of cardiac conditions and diagnosis applications, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride (Esmolol hydrochloride), a buffering agent, ethanol and propylene glycol. The ready-to-use injectable, co-solvents (ternary mixture) pharmaceutical composition is capable of being stored in a modified flexible plastic container that may be heat-sterilized without deformation and/or without having the integrity of the closure system being compromised. A method for the manufacture of the ready-to-use injectable, co-solvents (ternary mixture) pharmaceutical composition is also disclosed. |
| Inventor(s): | Owoo; George (Lindenhurst, IL), Castagna; Erica (Tirano, IT) |
| Assignee: | Welgrace Research Group (Lindenhurst, IL) HQ Specialty Pharma Corporation (Paramus, NJ) |
| Application Number: | 13/973,003 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Use; |
Drugs Protected by US Patent 8,829,054
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hq Spclt Pharma | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER | esmolol hydrochloride | SOLUTION;INTRAVENOUS | 205703-002 | Apr 7, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Hq Spclt Pharma | ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER | esmolol hydrochloride | SOLUTION;INTRAVENOUS | 205703-001 | Apr 7, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,829,054
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014228155 | ⤷ Try a Trial | |||
| Canada | 2906031 | ⤷ Try a Trial | |||
| China | 105263809 | ⤷ Try a Trial | |||
| European Patent Office | 2948379 | ⤷ Try a Trial | |||
| Japan | 2016515513 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
